CD34 and neoplasm: Research indicates that CD34-positive tumor cells can trigger an inflammatory response, leading to inflammation and damage to surrounding brain tissue, thereby increasing the risk of epileptic seizures, which clinically manifests as a significant association with a longer history of epilepsy (6).